VentureBeat March 18, 2021
Samsung Strategy and Innovation Center

This article is part of a Technology and Innovation Insights series paid for by Samsung.

In this episode of The Next Wave, Young Sohn sits down with Lisa Alderson, CEO of Genome Medical, an innovative healthcare firm that is working hard to ensure that genomic medicine is made accessible to everyone.

Alderson shares her views on a range of issues around genomics. She discusses the vast promise of the technology and her company’s efforts to bring its game-changing potential to all patients by providing clinical support tools to non-genetics professionals. She also addresses the ethical questions raised by genomics, particularly its use in prenatal diagnostics. And she highlights the critical role genomics played in developing COVID vaccines in record...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Health IT, Interview / Q&A, Patient / Consumer, Pharma / Biotech, Precision Medicine, Provider, Technology, Trends
STAT+: After AI protein folding, David Baker’s lab identifies millions of smaller drug candidates
Fierce Biotech Layoff Tracker 2024: BMS to cut 2K+ roles; Tessera trims workforce in shift to clinic
What Do Weight-Loss Drugs Mean for Diet Industry Built on Eating Less and Exercise?
Podcast #1: Doing Digital Deals in Life Sciences | Corporate Culture
BMS plans $1.5B in cuts through '25, with 2000-plus layoffs

Share This Article